InnovAge CLO granted 51,369 RSUs in award

DAMATO NICOLE reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/23/2026 - 04:42 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DAMATO NICOLE reported acquisition or exercise transactions in this Form 4 filing.

InnovAge Holding Corp. reported that chief legal officer Nicole Damato received a grant of 51,369 Restricted Stock Units (RSUs) on July 22, 2026. The RSUs will be settled in shares of common stock and will vest in three equal annual installments on the anniversary of the grant date, subject to her continued service. Following this award, her reported direct holdings total 328,711 shares of common stock.

Insider Trade Summary

Grant/Award: 51,369 shares

Grant/Award 1 txn

Insider DAMATO NICOLE

Role CHIEF LEGAL OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.001 par value F1	51,369	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.001 par value — 328,711 shares (Direct)

Holdings Before and After: Common Stock, $0.001 par value, 277,342 to 328,711 shares (Direct)

Footnotes (1)

1. F1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in three equal installments on the anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer.

Key Figures

RSU award size: 51,369 shares Holdings after transaction: 328,711 shares Vesting installments: 3 installments

3 metrics

RSU award size 51,369 shares Restricted Stock Units granted to chief legal officer on July 22, 2026

Holdings after transaction 328,711 shares Direct common stock holdings reported following the RSU award

Vesting installments 3 installments RSUs vest in three equal installments on each anniversary of the grant date

Key Terms

Restricted Stock Units ("RSUs"), vest in three equal installments, grant date

3 terms

Restricted Stock Units ("RSUs") financial

"Represents Restricted Stock Units ("RSUs") which will be settled in shares"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest in three equal installments financial

"will vest in three equal installments on the anniversary of the grant date"

grant date financial

"on the anniversary of the grant date, subject to the Reporting Person's continued"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did InnovAge (INNV) report for Nicole Damato?

InnovAge reported that chief legal officer Nicole Damato received a grant of 51,369 Restricted Stock Units (RSUs) on July 22, 2026. These RSUs will settle in common shares and vest over time, increasing her equity-based stake in the company.

How many InnovAge (INNV) shares does Nicole Damato hold after this Form 4 transaction?

After the reported RSU grant, Nicole Damato’s direct holdings total 328,711 shares of InnovAge common stock. This figure includes the newly awarded RSUs that will be settled in shares, as disclosed in the Form 4 filing.

What are the vesting terms of Nicole Damato’s 51,369 InnovAge (INNV) RSUs?

The 51,369 RSUs vest in three equal installments on each anniversary of the July 22, 2026 grant date. Vesting is conditioned on Damato’s continued service with InnovAge, aligning the award with ongoing employment.

Did Nicole Damato purchase InnovAge (INNV) shares on the market in this Form 4?

No market purchase is reported; the filing shows a grant/award acquisition of 51,369 RSUs at a stated price of $0.0000 per share. This reflects an equity award rather than an open-market buy or sell transaction.

What security type is involved in Nicole Damato’s InnovAge (INNV) Form 4 filing?

The transaction involves Restricted Stock Units (RSUs) settled in InnovAge common stock. The Form 4 identifies the underlying security as common stock with a par value of $0.001 per share, delivered upon vesting of the RSUs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DAMATO NICOLE

(Last) (First) (Middle)

8950 E. LOWRY BOULEVARD

(Street)

DENVER COLORADO 80230

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InnovAge Holding Corp. [ INNV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF LEGAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value	07/22/2026		A		51,369	A(1)	$0	328,711	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in three equal installments on the anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer.

Remarks:

	/s/ Nicole D'Amato	07/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)